Drug Database
Back to search

France· FR:65216768

POLYSTYRENE SULFONATE DE SODIUM ZENTIVA 400 g, poudre pour suspension orale et rectale

A medicinal product containing polystyrène sulfonate de sodium, registered in France by ZENTIVA FRANCE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPOLYSTYRENE SULFONATE DE SODIUM ZENTI…ATC—REGISTER NO.FR:65216768PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about polystyrène sulfonate de sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
POLYSTYRÈNE SULFONATE DE SODIUM
Manufacturer
ZENTIVA FRANCE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930199947
    1 flacon(s) polyéthylène haute densité (PEHD) de 400 g avec cuillère-mesure polypropylène
    EUR 23.64

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Polystyrène sulfonate de sodium in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All polystyrène sulfonate de sodium products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Resonium A
  • Belgium · Kayexalate Sodium
  • Cyprus · Resinsodio
  • Germany · Anti-Kalium Na, Elutit®-Natrium-As
  • Spain · Resinsodio
  • Finland · Resonium
  • United Kingdom (Northern Ireland) · Resonium A
  • Hungary · Resonium
  • Italy · Kayexalate
  • Luxembourg · Kayexalate Sodium
  • Netherlands · Natriumpolystyreensulfonaat Focus, Resonium A
  • Poland · Resonium A
  • Portugal · Resonium
  • Sweden · Resonium

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c835fc12-42bd-48b3-bb85-7159b3492a17
GET /v1/drugs/c835fc12-42bd-48b3-bb85-7159b3492a17?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65216768",
  "date_amm": "2020-02-19",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "POLYSTYRÈNE SULFONATE DE SODIUM",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour suspension et",
  "voies_administration": "orale;rectale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about polystyrène sulfonate de sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console